Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Holdings Boosted by Nuveen Asset Management LLC

Nuveen Asset Management LLC lifted its position in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 21.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,943 shares of the company’s stock after purchasing an additional 3,330 shares during the period. Nuveen Asset Management LLC owned about 0.09% of Tabula Rasa HealthCare worth $1,208,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. First Mercantile Trust Co. purchased a new position in shares of Tabula Rasa HealthCare in the 4th quarter worth approximately $39,000. TCI Wealth Advisors Inc. grew its position in shares of Tabula Rasa HealthCare by 1,600.0% in the 4th quarter. TCI Wealth Advisors Inc. now owns 850 shares of the company’s stock worth $54,000 after buying an additional 800 shares during the last quarter. Quantamental Technologies LLC purchased a new position in shares of Tabula Rasa HealthCare in the 4th quarter worth approximately $64,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Tabula Rasa HealthCare in the 4th quarter worth approximately $135,000. Finally, Riverhead Capital Management LLC grew its position in shares of Tabula Rasa HealthCare by 100.0% in the 3rd quarter. Riverhead Capital Management LLC now owns 2,600 shares of the company’s stock worth $211,000 after buying an additional 1,300 shares during the last quarter. 78.00% of the stock is owned by hedge funds and other institutional investors.

In other Tabula Rasa HealthCare news, CFO Brian W. Adams sold 684 shares of the company’s stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $60.00, for a total transaction of $41,040.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Orsula V. Knowlton sold 8,000 shares of the company’s stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $57.05, for a total transaction of $456,400.00. The disclosure for this sale can be found here. Insiders have sold 42,000 shares of company stock valued at $2,355,740 over the last 90 days. 14.00% of the stock is currently owned by company insiders.

A number of research analysts have recently issued reports on TRHC shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $99.00 price objective on shares of Tabula Rasa HealthCare in a research report on Thursday, February 28th. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “sell” rating to a “buy” rating and set a $69.00 target price on the stock in a research report on Thursday, January 10th. Benchmark began coverage on shares of Tabula Rasa HealthCare in a research report on Tuesday, January 8th. They set a “buy” rating and a $85.00 target price on the stock. BidaskClub raised shares of Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a research report on Friday, March 22nd. Finally, Guggenheim began coverage on shares of Tabula Rasa HealthCare in a research note on Wednesday. They set a “neutral” rating and a $58.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $81.36.

Shares of TRHC traded down $0.78 during trading hours on Friday, hitting $48.91. The stock had a trading volume of 356,330 shares, compared to its average volume of 336,560. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.84 and a quick ratio of 0.79. Tabula Rasa HealthCare Inc has a fifty-two week low of $39.06 and a fifty-two week high of $91.16. The stock has a market cap of $1.03 billion, a P/E ratio of 143.85 and a beta of 1.65.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Thursday, February 28th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.07). The firm had revenue of $57.31 million during the quarter, compared to analyst estimates of $55.70 million. Tabula Rasa HealthCare had a negative net margin of 23.14% and a positive return on equity of 7.76%.

COPYRIGHT VIOLATION NOTICE: “Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Holdings Boosted by Nuveen Asset Management LLC” was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/nuveen-asset-management-llc-grows-position-in-tabula-rasa-healthcare-inc-trhc.html.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

Further Reading: What are the risks of holding treasury bonds?

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.